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Oral submucous fibrosis (OSP) predominantly affects Indians and 
other Asiantics. Betel quid chewing, a part of traditional Taiwanese 
culture, is the most important etiologic factor for OSP. 
The cause of OSF is still obscure. Chillie consumption, betel quid 
chewing. nutrilional deficiency, and genetic susceptibility are believed ro 
be involved in the pathogenesis of OSF. In recent years, betel quid chew­
ing is very common in Taiwan. 
OSP is a disease due to an insidious. chronic change in fibroelastici ty. 
It is characterized by a burning sensation in the oral cavity, blanching and 
stiffening of the oral mucosa, and oropharynx, and trismus. Histopathology 
of this lesion is characterized by progressive fibrosis with other changes 
primarily in the lamina propria and secondarily in the epithelium. 
The symptoms/signs depend on the progression of the lesions and on 
the number of the affected sites. Early stage of OSF includes vesicles, t 
ulcers, stomal ilis, xerostomia or burning sensation of the oral mucosa, und 
alterations of taste. In advanced lesion, the fibrosis extends from the subep­ ( 
ithelial lamina propria through the entire submucosa to the muscle layer. 
Thick inextensile vertical fibrous bands appear in the checks, faucial t! 
pillars, and encircle rhe lips. Narrowing of the oral aperrure cau1->ed by p 
circular fibrous bands in the lips is not only disfiguring but also limits o 
oral access, leading eventually to malnutrition and poor oral hygiene. b 
OSP is considered to be a premalignant stage of oral cancer and asso­ iJ 
ciated \"lith an increased incidence of leukoplakia and squamous cell carci­ c; 
noma. If unl reated, the risk of malignant change in advanced case of OSF 
is relatively high. A high proportion of patients who develop oral cancers p 
are belel quid chewers and sometimes habitual cigarette smokers and/or 
alcohol consumers. 
This thesis comprises of 6 parts: a( 
ar 
ParI 1. Epidemiology of oral submucous fibrosis (OSP). A statistical report 
on the analysis of 439 patients (1982-1991) with oral submucous In 
fibrosis al the dental clinic of Kaohsiung Medical College Hospi­ trc 
tal. th 
an 
The epidemiologic data of the 439 patients diagnosed clinically and co 
pathologically as having submucous fibrosis at the dental clinic of the (c; 
Kaohsiung Medical College Hospital was elucidated. The results were tis 









(1) The sex ratio was 431: 8 in favor of the male. The youngest case was 16 
years old, and the oldest was 71 years old. 
(2) The peak frequency was between the ages of 20 and 39 years (70%). 
(3) 	A high attributable risk (98.6%) of OSF patients was betel quid chew­
mg. 
(4) There are 5.9% with oral cancers in 439 OSF patients. 
A more intensive observation of the oral condition of those betel quid 
chewers may need to be undertaken m order to obtain more reliable 
information about the disease and the chewing habit. 
Part 2. The background of the study on the treatment of oral submucous 
fibrosis and a comprehensivc revicw of the literature 
The importance of available treatments for this insidious. chronic 
disease of unknown etiology is elucidated. A high attributable risk (98.6°lc) 
of OSF patients was betel quid chewing in the present case series. During 
the lO-year period, cases of OSF were increased rapidly (12 cases in ! 982 
and 80 cases in 1991). It is a precancerous condition. If untreated, the risk 
of malignant change in advanced cases of OSF is relatively high. 
A wide range of treatments in the past givc the patients only symp­
tomatic relief. This may be mainly due to the fact that this diseasc is 
progressive in nature with unknown etiology. By a comprehensive review 
of the literature, it is generally held thal medical therapy alone is of little 
benefit over the long-term follow-up period. Conservative treatment, includ­
ing observation alone is not recommended. The surgical therapy are indi­
cated only in cases with advanced disease of trismus. 
Part 3. Clinical evaluation of different treatment methods for oral submu­
cous fibrosis. A lO-year experience with 150 cases 
In this article, the experience in the management of the early and 
advanced cases of OSF over the past 10 years was presented. In addition, 
an effective regimen for the treatment of this disease is proposed. 
Over a lO-year period (1982-1991), a total of 150 patienls divided 
into two groups with varying degrees of oral submucous fibrosis were 
treated by two alternative therapies: either (I) medically with (a) conserva­
tive oral administration of vitamin B complex, buflomedial hydrochloride 
and topical triamcinolone acetonide 0.1 or with (b) conventional submu­
cosal injections of a combination of dexamethasone and hyaluronidase or 
(c) with both (a) and (b); or (2) surgically by the excision of fibrotic 
tissues and covering the defect with split-thickness skin, fresh human 
amnion, and buccal fat pad (BFP) grafts. Treatment was chosen according 
-3 
to the stage of clinical progression \0 gain maximal imerincisal distance 
(lDL The cases were followed up by monthly examinations for at least two 
years, or whcn possible even longer. I found that a combination of (a) and 
(b) medical treatment was satisfactory in cases of mild impairment in ID 
of >20 mm, but in the long~tcrm it led to symptomatic relief only. Surgi~ 
cal therapy on the other hand, when accepted by the patients led to a 
significant impovement of trismus in cases of severe limitation of ID 01' 
<20 nU11. Following this strategy, an additional ID increase was observed 
in all patients. BFP grafting was particulary successful in diminishing scars 
after two years as compared with the other two grafts. Together with a 
cessation of the betel quid chewing habit before and after therapy, thcse 
treatment regimens combined with daily mouth opening exercises were 
found to be necessary to properly manage OSF cases in early and advanced 
stages of progression. 
Parr 4. Clinical experiences with human fresh placenta as submucosal 
grafts for the surgical defect of oral precancerous lesions 
In the parr 3, the surgical therapy by the eXCISIOn of fibrotic tissues 
and covering the defect with fresh human amnion is presented. The 
purpo.';c of this article is to present the state of knowledgc of the fetal 
membranes and to summarize lhe experience in the clinical application of 
this information as used by myself and others. The clinical trial is indi~ 
cated to evaluate them as oral submucosal grafts. I had treated 145 
patients (I 986~] 992) of oral precancerous lesions such as oral submucous 
fibrosis (25), leukoplakia (120) in my dental clinic. 
The most striking features of clinical results were the iuunediate adhcr~ 
cnce, marked relief of pain and protection against superficial bacteria infec~ 
tions. Similarly, the recipient sites of rccpithelialization with pinkish cover 
ing mucosa, no significant scar formation were noted after one month of 
observation. They were of clinical values. 
Part 5. Dirncthyl sulphoxide extract or betel quid inducement of oral 
submucous fibrosis (OSF) on the buccal mucosa of wistar rats 
To consider the limited specimen of human buccal tissues from inci~ 
sional biopsy procedure, the extract of betel quid inducement of oral 
submucous fibrosis (OSF) on the oral cavity of animal will be needed for 
me. The further investigation (both in vivo and in \fitm) for OSF can be 
engaged by this induced lesion via local painting of dimethyl sulphoxide 
(DMSO) extract of conm1ercial betel quid. 
























ogy of this lesion. This paper reports the attempt at the induction of OSF 
on the buccal mucosa of Wistar rats. The results are summarized as 
follows: (1) The varying degree of OSF on buccal mucosa induced via 
DMSO extract of betel quid application in Wistar rats. (2) After 24 weeks 
of application, the induced lesions in the form of patches with opaque 
appearance. In addition to the epithelial atypia, the underlying connective 
tissue showed portion of homogenization of collagen bundles. (3) The 
induced lesions on the buccal mucosa of Wistar rats were not markedly 
reduced or absent after the end of experiment with either the continued 
painting or observation for a period of 12 weeks. (4) The human lesion of 
OSF is not identically reproducible in laboratory Wistar rats. 
Part 6. Dark epithelial cells in oral premalignant lesions 
Oral submucous fibrosis (OSF) is a chronic oral precancerous condi 
tion. The atrophic epithelium first becomes hyperkeratotic and later inter 
cellular edema and basal-cell hyperplasia develop, eventually followed by 
epithelial atypia with moderate epithelial hyperplasia. There is a good 
correlation between the degree of atypia of rodent and human epithelial 
preneoplastic lesions and the number of dark epithelial cells in the respjra­
tory tract mucosa. I attempt to correlate the distribution and frequency of 
these cells with the cljnical type and degree of atypia in these lesions such 
as oral submucous fibrosis and leukoplakia. 
This result revealed that the increase in the number of D-cells in the 
basal epithelial layer was in proportion to the severity of the epithelial 
dysplasia. Thus, the D-cells probably can be used as an indicator in prema­
lignant lesions of the oral cavity. 
Key words: 	oral suhmucous fihrosis, hetel quids. placenta. huccal fat pad. 
induction, dark epithelial cells 
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Part 1. Epidemiology of oral submucous fi brosis (as F). A statis­
tical report on the analysis of 439 patients (198 
1991) with oral submucous fibrosis at the dental clinic 
s 
of Kaohsiung Medical CoUege Hospital. 
g 
The epidemiologic data of the 439 patients diagnosed clinically 
and pathologically as having submucous fibrosis (male: 431. female: e 
l. 	 8) at the dental clinic of the Kaoh:-;iung Medical College Hospital 
were elucidated. Clinically suspected cases were confirmed either 
with the regular incisional biopsy. or with a punch biopsy for the 
severe limitation cases under local anesthesia. The specimen were 
fixed in 10 percent formal i n solution and then stained with hema­
m 
1- toxylin and eosin, and Lillie modification of Masson Trichrome 
stains. The pathologic observation of oral mucosa includes the basic 
\. 
LI­ changes of the connective tissue in the lamina propria and with 
~d 	 regard to the thickness, type of keratinization. atypia. and characteris­
tics of malignancy in the epithelium. Detai Is of their daily habits. 
d, 
such as liquor 	 drinking, tobacco smoking, use of spicy foods, or 
n. 	 betel quid chewing, were obtained and recorded. The results were 
J. 
summarized as follows: 
(1) Analysis of incidence rates over the last 10 years in Taiwan show
th 
ry a steady increase in male suffering from aSF. The sex ratio was 
431:8 in favor of the male. The youngest case was 16 years old, 
and the oldest was 71 years old. 
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(2) 	The peak frequency was between the ages of 20 and 39 years (70 
%). 
(3) 	263 (60%) of the patients suffered with the limited mouth open­
ing. The severity of the trismus varied from 10 mm. to 35 mm., 
measured between upper and lower incisors (interincisal distance). 
(4) 	According to present results, buccal mucosa is the site of maximal 
involvement. Next in frequency was the palate, retromolar, lips and 
tongue. Most of the mucosal changes involved more than one 
particular site in the mouth. The uvula becomes small and 
distorted. It appears as a small fibrous bud. 
(5) 	A high attributable risk (98.6%) of OSP for betel quid chewing. 
Betel quid chewing was found to be significantly associated with 
gender, age, educational level. occupation, smoking and drinking. 
About 87% of betel quid chewers was a cigarette smoker and 73 
habitually consumed alcochol. 
(6) 	The relative risks for OSP are very high for all forms of betel 
quid chewing. 
(7) 	The average daily use varied from 10 to 25 grains per day. 
(8) 	There arc 25.0% with leukoplakia, 0.1 % with lichen planus and 
5.9% 	with cancers in 439 OSP patients. 
A more intensive observation of the oral conditions of those 
belel quid chewers may need to be undertaken in order to obtain 
more reliable information about the disease and the chewing habit. 
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s Part 2. The background of the study on the treatment of oral 
submucous fibrosis and a comprehensive review of the 
Ii terature 
The importance of the available treatments for this insidious, 
e 
chronic disease of unknown etiology was elucidated. A high 
attributable risk (98.6%) of OSF patients was betel quid chewing in 
the present case series. During the 10-year period, cases of OSF were 
n 
increased rapidly (12 cases in 1982 and 80 cases in 1991). It is a 
precancerous condition marked by mucosal rigidity due to the exec­
s: ssive deposition of collageneous tissue in the juxta-epithelial region. 
If untreated, the risk of malignant change in advanced cases of OSf' 
IS 
is relatively high. 
A wide range of treatments in the past gl ve the patients only 
short-termed symptomatic relief. This may be mainly due to the fact 
at that this disease is progressi ve In nature with unknown etiology. A 
m 
comprehensi ve reVlew of the literature revealed that medical therapy 
t- alone is of little benefit In long-term follow-up. Thus conserati ve 
treatment, including observation alone is not recommended. The surgl­
s: 
L 
cal therapy is indicated only In advanced cases with severe trismus. 
These surgical treatments are strictly palliative and they only relieve 
the trismus temporarily. 
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,·h '=-1 4··~ 
~£i,~ ffi 
fllc ' :u: !fJ,qW : fgJ;:k: 
!M -fi ~Jldil~ ~ , M' ~~ii 'J' ::;' g: m.L Ern ~rJET 1fT 0 :flj MHtf ~~ ~t ~ '!f# 
~~•• m~'1ffE:f]'~.M~ ~~(~)~~~m,~ 
, !'.11:-q;~ * bJ fi§£ @ fit i$ i¥1l 0 WlW; l:~ --, ~¥f ~!JlIH~W ' #} I'j; !l!ij 
~*If ' ~.1&. ::1-: lit} ::w 1=k ' ~w~1If 1f Yrj 0~ 6J ' 00 f;L o:w 
fVlI m m ~ , ~~': ~ ::;' ffi ~1=k m , It! [JEf ?¥f ~ :r~ ~ ~ ~ 
@.~~~,~~~~~~*~~#}~ W~.~,!'.11~~ • 
~~~~w~~~~oU*~ro@~y .~~m••* '. 
4R 1 BtHfU) 
(3) *Y:. ::5€ X Y:. ~ ~~ 11:: ~ ~ D ~m:@. ~ it~ itt (J Oral Pathol 
Med) ,jft ~ 'JtfU ~ 0 Clinical evaluation of different treatment 
methods for oral submucous fibrosis. A lO-year experience with 
150 cases. (Accepted for publication May 10, 1995) 
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Histo-Pathological Staging of Oral Submucous Fibrosis (lamina propria changes) 
Very early stage: 
L Fine fibrillar collagen (dispersed with eder~a) 
2. Fibroblast response is strong 
3. Blood vessels: dilatation and congestion 
4. 'nflammatory ceils (PMN) increased 
Early 	stage: 
L Juxta-epithelial zone: Early hyalinization 
2. Collagen: Separated LJundles 
3. Plump young fibrob'asts 
4. 8100d vessels: dilatiltion and congestion 
5. Ipflammatory cells: Mononuclear Iylllphocytes and eoslnopnils increased, less plasrfla cells 
Moderately 	c'.ldv;:\I1ced stage: 
1 MOderately hyalinizated 
Z. Thick.ened collagen bands 
3. Decreased fibrob!astS,ncreased 

4 8100d vessels: contract'on 

5. Inf!arnrnatol'Y ce!ls: Lymphocyte, p:asrna cens Increased, decreased eoslflophils 
,L\.l~vnnced !:.;t(J~e: 
1 Complete hVillllllzatlor! 

~Jo c:epilriited bundle discernibie 

3, Cdema disappear 

4. Blood vessels! completely obli:erated or narrOwea 
5. ceils: lymphocyte, plasma cel!s increa'oed 
f=rorn Pindhorg JJ, Sirsat SM. Oral submucous fibrOSIS, 
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n. rJJ !Ii l.!1 
1. 	 Hyaluronidase Gfstoweft!!:it1f.1nfU:iiilil:X· &:i'ilgdtl!2.~ii'*JUl\izrw~ 'fil'JiJif{;rrrr.~)JnM!~HR!'\f{t-J Acetyl 
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3. *~'1l1ii1:fti~~tJ!l!W&BZ;S'lJff!Wmli~zS~TJ1' slEWi:kiffl'i'liffijf,1 e 
(~F ~ -'* fit ~) 
1:.ttlltt: Mouse Z LD", ItTL=:lttlh'fm 250,000 rlH:!:/kgJJ.J: ' firJ:]V'l2:::j;i\ 12.500 ;·,li;t/kgru. c 
(tt lI;I;] 
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I (BUFlOMEOll HYDROCHtORIDE! II 
O....rIt>UOll 

BullOmedil hydrOChlOride il • vnoaclive 

allen! which i""teaMS tile peripheral and 

cerebral blood flow in Impalnl(/ ..acul., 





Buftomedil hydrochloride is identified 
chemically as 4-!1-pyrroiidinyIH-(2.'.6­
lrimethoxyphenYI) ~ l-buisnone hydrochIO(ide. 
Empirical formula: C 1,HuN04 '"HC: 
Structural formula: 
OCH, 
H,Co-Q- ~ -C~-<::H,-CH,-{]. HCI 
OCH, 
tntravenously or intramusculany; and wtutn 





!n vitro p(otein~binding studl~ of 
buttomedfl in human plasma have ahowo 
81% of the drug to be bOund"t 0.5 
mcglmL. 61% at 5 mcgfmL and 25% at SO 
mcg/mLTt".us. at plasma concentrations 
obtained Clinically. 1M pOteNI81 for drug 
rnteraclion due to displacement of highly 
bound drugS appears to be I"w. 
Toxicology 
Chronic tOXicity studies were conducted in 
rats and dogs by the or.. anO parent.tal 
routes of administration, Under condition, 
ot these studies no 9rO$S organ 
abnormafiHes were o~ in tt\eH 
species. (Oral "'no tQxic-effect'" dOH lor 
rats: SO mg/Kg b,wjdcy; intr.veooos ....flO 
toxlc·eU1!Ct- dose fOI r.ts: 12mgl Kg 
b.wJday.orof "no tOxIC.....Uecl.. dose for 
dogs. >20 mg and"" 40 mg/Kg b.w.ldayl 
Convulsive seizure'S have twlt6n reponed m 
anImals treated with high doses 01 
buUomediL 
ln a slx*wook oral toxicity study In 
Immatule rAfs the '''no roxie effectti dose 
was 200 mglKg/day 
Mula\lenlclty Slue/leo 
SuBorned;! was found to be non-mutagenic 
to bone marrow chromosomes lfl ma1e (aiS 
at dos.s 01 SO. 100. Bnd 200 mil/Kg by 1M 
oral rOute likewise. th., results of the 
Ames mutagenicity te$t were n&gatll/e. 
Carcinogenicity 




Pharmacologlcany. butJOmedil ha3 beet'! 
,hown to increase th\t arteria. perlusion of 
tile micnX;I(Cufalion with minim.' ",f'eets 
on central he<nodynarrllCS when 
admmlstf)(ed at (4COmf'nendOd 005e'S. It 
exhibi!s inhibitory efl6Cts on pllteler 
aggregation, and ImprOYfJ:~ the 
deformabdlfY of eryt:hrO(:ytes with 
4ooor",.1 tlu,dity. Alth(hJgh tn.e 
mKhaOfSm{S) by wNch butiorned!1 
tnlj,uc;;es these tffeets halle nor yet been 
conclusl\;efy de/n'led. preliminary data 
;iuggest that a weak. non-specific ea + .. 
IntlfjlOmsli(: effect (in Vl.!!.9 oniy) and a 
non"speclf,c alpha-teeeptor blockfng ~t1ect 
are involved, It INst fn pert. 
SIngle and multiple dose u(ety .fl(j 
pharmaco«:!netic studies have shown lhat 
Sullomedil He!: 
ill 	 was absorbe<J rapidly trom Ihe Gf tr:act 
when administered orilly (maximum 
serum cOO(;entration 1.5~3.0 hours) and 
entered the systemic Circulation 
primarily in an unch.ng'" larm (55-80% 
biOttv!:ilable): 
b 	 h3l,d a reiaUvt!ly short plasma biologicat 
halt-life (1.91-3.65 hours): 
c. was metabolized ",,"'nllvely (low 
t)itrcentage 12..2MII of tJrinaty excretiol1 
of int.ct drug o~r.a hours); 
d 	 was .,Ktens! .... f)' di$tribuled through 
body fluid compartments alllJlo: tissues 
(apparen! volume 01 distribution 80-100 
liters); 




BuflomedJI HCI's phannacokinetics wers 
linear within the dose range studied. (50, 
100 and 200 mg. LV. and 1SO. 300 and 450 
mg orally) li$ bi08vaifahility was equh/alent 
wf'len administered in the sarne dose 
and mIce of both 5eJ(.f:S (oral).buflomedil 
pn.?ved to be non-oncogenic under the 
condItions of thew studies. (Oo-$8ge in 
(iUS: up to 400 mg/Kglday: dosage in mice: 
up 10 1200 mgIKgfday). 
Teratology 
No terllogf!nlc effects ot bu1!omeoil were 
obsef'\led in female rniea and rats at aral 
dou. up to 200 mglKg/day in .... Is .nd 70 
mg/Kg/day in mtce. No advetH eft1!Cts 
were ObHf"tf!O on the growth and 
dev~lopment ot the: pUP' of dams treated 
with buf10medil during gestation da):S 
15-21, nor did ,tudia of reproductive 
performance in the offspring 0' Ireatecl rats 
$hOW any effects on mare Of female 
fertihty. ·\tSlrous cycle. partufWon. gfowth 
and survival 
IndleatlQM .nd Uuge 
Suflomedil hydrochlot"ide IS indicated in 
Ihe treatment 01 intermittent cfaudlC8tion, 
Ischemic rest pain and trophic disorders or 
skin uicer3hons due 10 chronic arterial 
InsuffiCiency. as welt as in Raynaud's 
Disease, Aaynaud'$ Syndrome and other 
vasospaS!l<': disorders such as liv~o and 
acrocyanosl$ 
Buflomedll hydrOGh!oride is further 
tndlcated In the treatment of signs and 
symptoms often associated wIth either 
chrotliC cereo(ova$cutar insufficiency or 
aging 
" !,Iet1lgo. tlnf'lilus, dizziness; 
" Intellectual deterioration, 
• changes in persOflality and socio-fsmilial 
behavior, 
.. msomnia~ 








8vf1omedil Hel is controindlOll'*<l in 
individuals who M¥e ~ousty~n 
hY_Mltivity to a-.., druo. Buflomedil 
HCI ts also contrll1ndieated im"'*'ta~fy 
postperlum or in the ",,,,,flee of arteria. 
bleeding. 
Before prescribing bullomadi' lherapy, 
the ph)'$i¢ian sIlouk! exclude the 
pouibility thel the pelienr. sic,lns and 
symptom. arise ,rOm I pot .... U.11y 
",..rsibIe and t,..1able condition. 
Parlicul", <:aN ."ould belaon to 
"><dude delirium I fld dementl-Iortn 
01.... .-condary 10 systemic a_, 
primary .....roIog!ca1 dl_. 0< primlry 
disturbanoe 0( mood, 
w .......... 

Usage during pregnancy and in children: 
Due to lac\( 01 ldequate clinical 

experience to date, the safety 01 

butlomedH for UN during pregnancy or 

lactation has not been 8It&blisMd. 

Aa clini"! dati In children are not yel 
an;labfe. the safety and off.ctiwnns of 
buNomedil .dministratiOl'\ in this agO) 
gnoup has not y<lt been OI$18bl_. 
S.I<IIy 
Buf!omedil was Idmioblered orilly and 
by sey ..... 1 parenterll rout". (IY.tld, end 
Intr.-crterilllly). In lhe therapeutic trials" 
was common p,:o&ctice to initiat. 
buflomedillhe....py by tn.. intflYenQUO or 
intramuscuhu route and foUow th!'S with 
oral adminhtratiQn. jn patienu with 
cerebrovascular insufficiency, hQwewr. 
the drug wa, administered by the Qral 
root .. ol'\ly. The daily oral d".. nIIlge 01 
blJllomedii was 300 to 500 mg in dMded 
d()!lf!O; mO$I patients recei""" "aily doses 
01 4SO or 500 m~ (1 !ablet tIlr... II""," • 
Drug InteracUon 
No drug interaction has ~n reported 
w;~h buflQmedil,· 
• ExceptIon: 10 one study, 
decreases of blood ghlcO'le leIte'S 
were 0b$4fV8d in diabettt patients. 
simultaf"H!Ously treeted with oraJ 
antidiBbetcc drug, The doubl&-blind 
,hJdy with bu'lomodil and 
gllbenclamid<> di<l not SOJppart said 
observation. 
oouge and Admlnlolnotlon 
Tabfets: Three or four l50mg tabf.et! 




Overdo,age would be expected to b43: 

manaested as tachycardia end 

hypotension. In a compi!ation of tW60ty~si)( 

cases of acute to)(ic reactions doe to 

ove,douge 01 buflomedil (dose. up to 

9(X)O mg) done at 8 major POtsO(\ control 

center. the following s,ymptoms. were 

mporteo, peripheral ....8'0011'1100. slnu! 

tachyc8l'dia, vomltmg. somnolence. 

coma-stage i-II. agitalion, conl,lut~ions. 

T,C'atrnerH of O¥.tdt)~ 

10 'case 01 OV6(dostlge. suppcrtive 

meBsureS should ~ taken. If cerebral 

Excitation occurs, administration of a 

beoZOO13zepine snou'id bt' conSIdered. 

_ntatlon 
loltyt.Tabt."lllSt No C997).r. supplied 
day or four ti_ I dey). The daily 
parent.rat dOIM range of buflomedif was 
100 '0 200 mg. 
In &ludi ... conducted by La'on. 

bullomedd (FQNZYLANE) his ........ used 

orally In d...... up to 900 mg dlily. For Ih. 

I.V. fQute, the usual daily dose fl'fIge .... 
300 or 400 mil. For the jntrom~ar 
rout•• the r.o~ was 1Qrnewt\4tt Iower~ 
Irom tOO to 300 mg deily. T__lI"S 
exceed th. maximum ora. (f500 mg,. 
intravenous (200 mg)and inlramusculolr 
(ISO mg) daily doMgH recommend<Id by 
Abbott. 
The uwat duration of intravenous 
thenlPY was 1010 50 d~, and oral 
therapy ranged fmm 10 days to 50 
months. G_nllly. the t_\ment 01 
cerebrovascular insufficiency was MOst 
p~()noed. with mo.t of the .too... of .b:: 
month3 duration, 
Pre- and po$t~treatment eUni"1 
laboratory tests (hematO(ogy. chembtry. 
urinalysiS) .......Ied no elQoilicanl 
laboratory abnormalities. no definite 
patte"",. although there _e _ data 
.uOges_ of r8n81Inv04_ (MfUm 
creatinine and BUN increase). No cause 
end eHeet retatiooshlp to the drug was 
establish«! Q ttlts was also obIerved in 
some patient, receiving pfacebo. 
Adft.... R._ 
In the majority of C6H$. adverse effects 
were of a relatively minor nature, The most 
commonly reported adve.-.e rea<.::tions 
among patient. treated with btJllomedil 
were (in order 01 decraa"ng __"'nee): 
vertigo, tw!sda.ehe. gastrointestinal 





Caution: Food. Drug and eo"metic Law 
prohibits dispenSing without prescription. 
a Manufacture<! by: ABBOTT LABORATORIES Mandaluyong. Metro Manila Philippines 
10 s.trips 0110 tablets, pdcked in bOxes of 
100's. each t.blet containing the *<Iuiv"j.ent OR-XS44401·2035/RQ-l0j9t C 






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































II! 3-1 	 o~tsJDtl';i.-Atmi:..~J1f#1:il (i5C. 26 it~tff!) ' .LiU~ (~ .;l:+1!l ' 
2% ) , ~~~~ l!l al (dexamethasone sodium phosphate, MSD) (!A 
1N ..~~:y',;jtWUit) 1 'J'M.~J.t4-i§t~ (hyaluronidase, 200 U.S.P. unit! 
mD 2 ~~ ( E1 ,*-#l!1~~**-;;'1t~J:. )(A) o ··.~*o ?;j,;}t.~~JlJt l'ii.M 
tai:..t.aj.ft~ , *1fij1ft..i.i:..5i.*tt~,l! 0~2 ml ;~*, i'{l , miii!iti:..ir,t 
Ji.$!J 1.5 mm Ii.;t; (B) 0 
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III 3 - 3 1\ m,~, ~ ( 1l 0 Ji.:k.;f-} 35 mm ) .t~ i: 4 l@..z.. 0 J1~m~l $~~ 1tE. ;!k ~t 
UiJ ( ~4In:ft"f~W-1J<.Jte) lrM~~;:" ( A : Yci*-M" B : $~.{~) o Bt 
&l ,~, -t- ( ~ 0 J.t 1t#- 30-35 mm ) t .t~ ~ 10 ik.z.. 0 P-l #6 mt r ~i. -M itt. 
.m~~t ••.z..**J.t.~o4~.~M.z..~.(C : Yci.~ , 




o £'~r~-*,:i!""lf £§-WW"$~ar 0 (0) 
':Ir~~-r~.(',*,cg~.. ' (J) 4~.Y~*~*~lf1 ' "Jf-([re: OZ~:j) n~(iJr 
-Wcg~W.~W~.~~~••W~.un~T••#.O~~ 
( If-*"ff~ 
:B ' ••~:V ) o~~~~~y+~.~~(~oti¥~~* 
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Part 3. Clinical evaluation of different treatment methods for 
oral submucous fibrosis. A 10-year experience with 
150 cases 
The management of early and advanced cases of oral submucous 
fibrosis (OSF) over the past 10 years was presented. An effective 
regimen for the treatment of this disease was proposed as well. 
Over a 10-year period (1982 1991), a total of 150 patients 
divided into two groups with varying of OSF were treated 
by two alternative therapies: either (I) medically with (a) conserva­
tive oral administration of vitamin B-complex, buflomedial hydrochlo­
ride and topical triamcinolone acetonide 0.1 ) or with (b) conven­
tional submucosal injections of a combination of dexamethasone and 
hyaluronidase or (c) with both (a) and (b); or (2) surgically by the 
excision of fibrotic tissues and covering the defect with split-thick 
ness skin, fresh human amnion, and buccal fat pad (BFP) grafts. 
Treatment was chosen according to the stage of clinical progression 
to gain maximal interincisal distance (ID). The cases were followed 
up by monthly examinations for at least two years, or when possible 
even longer. A combination of (a) and (b) medical treatment was 
satisfactory in cases of mild impairment in ID of > 20 mm, but in 
the long-term it led to symptomatic relief only. Surgical therapy, on 
the other hand, when accepted by the patients led to a significant 
impovement of trismus in cases of severe limitation of ID of < 20 
- 85­
mm. Following this strategy, an additional ID increase was observed 
in all patients. BFP grafting was particularly successful in diminish­
ing scars after two years as compared with the other two grafts. 
Together with a cessation of the betel quid chewing hahit before and 
after therapy, these treatment regimens combined with dai ly mouth 
opening exercises were found to he necessary to properly manage 
aSF cases in early and advanced stages of progression. 
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Pan 4. Clinical experiences with human fresh placenta as submu­
cosal grafts for the surgical defect of oral precancerous 
lesions 
In the part 3, the surgical therapy by the excision of fibrotic 
tissues and covering the defect with fresh human amnion was 
presented. The purpose of this article is to present the state of knowl­
edge of the fetal membranes and to summarize the experience in the 
clinical application of this information as used by myself and others. 
For several years, the author had used the human fresh placenta as a 
living dressing to cover oral surgical defects. The membranes were 
aseptically removed from the placenta, with no attempt being made to 
separate them into ammion and chorion. The clinical trial is to evalu·· 
ate them as oral submucosal grafts. One hundred and fifty-five 
patients (1986-1992) of oral precancerous lesions such as oral submu­
cous fibrosis (25), leukoplakia (120) were treated in my dental 
clinic. These large open wounds with partial/full thickness defects in 
need of placental grafts were chosen for study. The prepared intact 
membranes placed on the wounds were let fixed with a protective 
appliance such as resin plate/stent for 5 days to prevent dislodg­
ment after excision of lesion. 
The most striking features of clinical results were the immediate 
adherence, marked relief of pain and protection against superficial 
bacteria infections. Similarly, the recipient sites of reepithelialization 
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with pinkish covering mucosa, no significant scar formation were 
noted after one month of observation. They were of clinical values 
according to the followings: (I) the nontoxic and nonantigenic nature 
as well as their adherent qualities, (2) easily moldable and nudergo 
resorption after a period, mechanically preventing refibrosis, (3) 
avoidance of both the oral discomforr such as rough and wrinkle-like 
surfaces of skin graft and additional wound of leg, and (4) no cost, 
easily procured and conveniently stored for OPO clinic use. Thus, 
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BA • ~J E[l JJf 1¥; ffl1¥.15!a ?f!~!l?U ~W*4 ~m (chilli) ~ rUJ (2) ::£. tJ): a ?ift Jj• 
~ (34) 0 1959 if • EIJ JJf ~~ Sirsat ~ Khanolkar(56) ::tt: fqj tN ~ 2 :m :f[ 
m2.0% ~ capsaicin f:j): ~ mU W q:t fIVt z}i B ~~:i fIB $ B fJl1j [3 
M~:g~ , ~*~ capsaicin ~~ 51 ~ ~ ~ 1¥.1 ~fi ft'tf~;§ ~ &. JJi ' :Jt jt ti!: 
ff~ 0 
mmm~JjOO~~fim~:~Hma~M~~~~~••*~fi 
*~ ••~~••m~ ~••~~~~tt~ .,gmmB 
.,~.m~~fflW~.~~o~)~JjOO~.~ •••~B 
Wlli m.D~~~tl' A~~fi-~.~ ~~'~~M. 
rn~ffi~ffll¥.1~.tt.W ~n~.MW~~tl~m~••~~ 
.~~~H:Hr~Uft11::~1:± (5-6) , 1'F~*~U A1P-n11l1~5fljffl 7ti § mu 
ll~.m ~~m:l:t rm 66 ( iff - ) Jl'S( fiX; 1+ J...:,( {Jf!:ft 8.M (Wistar ral) 
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lm :WOO;~ ~Yrn 
Ii1 tn :u ~L: ~J ~Y* a# ~ jg] :f* rI Yi 2f( -=r ~ ~f ~(:L) G lliJ L12'J 
l3:t ~~J J* • ~~~g ~:Jt ~~* -ff. DPr fJtf W~13* rm ' Jig !if 4!-± $ mW 
( *f ~lIlH~W liif?Jf ) H*:U 2: =ry, W 711 iii (z,) 41f rtri l ~~OQ: ~~ft-~ 
Et;I D m :Jt H* *f ~~(1) ~:J1 ~711 1:113* -& 5~ flM =t1 Hi ~ ~ 
'.~W~-~~BH:. Y~~~~WWL:We~~~~. 
~T~.~~.tYi'~ ~ ,~W .~.m.~~ m~ 
~~~Yi••moo ~~~~~,~~o. ~ Y~~~D 
:st1ll@lO 
Btt~0 ~~m~.D~~.~~.- ~HD~~*~ 
(pg *i! J;), l;,Ui~dl:: j([g f~ 0 ~o Ranadi veO-S) fljffi ~ ~IU5z_ ~ l€ Jf:x i'EEi5 ~ 
1* ~ • ~~~ ~*~ !F- W3 ~ ErJ lJi * Suri(9) m tU J;),.f'tm ~ - Ef3 ~0 
(DMSO) ¥ If:x :fJU1~I\ ~ JJ[1J5; m10 12 ;i!!I W: 1* 1& ~ iflH51 Jlj ~ fffi 
~j 15 Y< mmz ~ :IN: fl (carcinogen) ; :tE flli ~ ,~ r:p m! ~~ tJ[J 1J5; m 
m~ ~ JJi, tJo 5$ ~ it ff m~ fJl 0 Hamner ill (10) 1J\ ill ,~ r:p tfi m 
-W~1fi:R~W3~1J5;1?t1?t~A ~. ,"01 3::~ ,'iI:: 
Ranadive(7) .~t-lE tUJ;),~m~m!~1J5; C17 mice ~~~ 5f!tEm 18 
£ 20 @I J'3 .@ ~E. ~:J& " Saikia(1I).l~ /f fit] r.- ;j)l ~~ -=f ~ 15 Y< ~~ 
Albino rats ~* Jffi jl!!J 15% WI] ~ .fiX; ~ ~ 1'0 tU 1fil Rao{ 12) f;R mil::0 
~ Jitlj Benz(a)pyrene lW m~f' ~ 31Ci~. ~, fJi, ~~ tJ( m 5fiJ 
Benz(a)pryene flJ ,1;), :I:W V[J D fl. $' ifl ~ 
pyrene im ~ "" ~~ fl1 J;):m: m1$. mz ~*~ •0 
/-- @7K d!': '8' fl';(>- Y, 7f­~ pg W3 ~ (1966)(4) J;J m 'E ij( z ~ 151 tT ~ 1ti': ~ I~ , ~:'t~ 
j{J!! 17 1 9 :i!!! z tfdft ~ • f!i i:f {oJ ~ t£ ~f I:: ' :n- Y<m~~m 
§1~~!F-~0 ~~fpHr2 0 
J: ~ ~ P'J )tf- fF -1ft pIT rr ~ ~ tE "" 11:: If ,~ ~6 ~ cf1 
tp: mt1 ( £ Jff ) Z m (~il::) 3&! 1J5; JJi z fri'i mil ~0 
11:: ~,tE ~ -~u M m 1± r:p , ~ T zP: a _ z JJi -f fiIiJ 19 11 rf{j 
~ -m:t* ti T ~lUI* E r::j< ~ z ~~ tl& (13) )tf- ' D ~~mrT _ 
*it 11:: :JJE :±: ;fJ1 ~m ~~ 11:: ~!J 1~ 1J5; $: r flll 11 Z ~ Mt ~ 7J • 
$l~1I::W 1it:itfJil¥JlWJJjf a (2,14-15) 0 rm~tfj:li£1JTm .,I&~~~ 
'Ii ~u f~ ~ )ti-I¥J Sirsat fA! Khanolkar(5-6) 1J5; 1959 A fit]. i* m 
~ z ::E g1t 151 capsaicin ~ 1* a • 0 Il?iZ ~ g~ ¥~ 15 ' rm ~ j7g ilp 1J5; 




*.t *~ jij15 5$.; 
:$:UFf7'e ~j$-OO *;<:it .M60~5t~4MHA, BWC,D) , 
A if,n 25 J;) ~~ tJ<.:fjt m mot ' ffi:f B if,n 25 ,L?), ;'ff tJ<. ~m 
~J:COtNCJ;},li1'f~ Ef3 ~ (Dimethyl sulfoxide, DMSO) ~m~J ( ~), 
C,Dm5t~ ~,n tJ<.m~m(~';'ff tJ<.~~~a.=~~ 
ffi ~U ) :fr 4 • fjiHM WA E if,n tim • EfJ ~ lf1 ~J if,n 2 ~ , 5} 7:JV J;), 4 ~~ 
~ ( - ) 16 izt :fr ifJ1 ffi ~ 1.'& )i: Jtfj ~ 1* ' BP[fl!] JE ~ ~. 
/\ Iffi ~ ~ ;"!f( t* ( ~ ) EJ.M [l ~ , ~,;M 36 ~ . ~ 12Z A, B 
ifJ1 1)- 5-} Pf:i IJ\ ifJi, IJ\ ittl ~ 1*1= izt JflUt, 1J \ if,ll ~rJ 
~1*ffi:f*.~'~MWm]2~oSOO W.~~OOffi~••• 
it .~~.'~~fi O~M$ ~~~ ~~~~WW.~ 
yfl!.> ,r;r, :r.Hl ,I§I. rn: ?~ ( I q '"'& ~~ Lillie modification of Masson 
Trichrome ~ -ES) () PlI'~ 
~ 1P'J -'::E 'f- IIlt ':f1.. , ,J.::.f, rn 
:f';;] ~ 48 {~ mti: 0 
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** !if! 
(-) t1 ~~ Zib n~ 7r :jiJt i'Jt JL : 
1. ril 5 ~ ~ , A, B f;\fJj Nfl ~ 1'f 0 ~ ~~1R W ~ Z ;EJL~ 
3. 1*24~~' AifJ-l16/25(64%)J)iJB*l3.18/25(72%) [3m rJ~ 
fE5t ( 5-2 A, B) , C, D ifJl. 
'i± ( 5-2 C, D) 'iffl C, D mJ3. ~~ *­
mi.± ( rm 5-3A, B) • ~~1&. ~~ 1* fj " ifl: Y<: m¥ Jfilrt 
wt~ ~ fi (/f.:y 1* {:f {iiJ!f?!J )( til 5-4A, B)12 ~ 
1:~ 'f;\fJj z if 'Ii: 7l- fi jf';J *± ~1ft l~ ;§ ffl' Z ;EJi! (rm 5-3 C , D 
W rm 5-4C, D) 
(-Hll~~MJ51~tJJ J:t ~ i'Jt JL : 
1. 1* 5 ~ ~ , A .. B f;\fJj ifJ1 Z ~m~ t{ ffj {t, ~~ tf .13. ~ 
flm ·mT~.m.m~~M~~•• ' ~••e~~ 
/f fR:g;, '1fn 11 ~ j?k: ~" llIl J;J- JEt 1ff1R tt. ffiI 1m 0 ( IfiI 5 
A, B) 
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o (a';) 9-~ r~ ) 
filIllIFHljf M*:f@ #t § ILL fim ffi~ :ftH¥ • ~ ~ Ern ~% fig ~IijT • rg~ 
mnw I¥ gr 05£:1: 1f z&-~ '~l, fie ~j 'iff W~J ~ , ~l ~ 9£ ?¥f '[7 
o (s'y 9-~ 
i!f!Mf~~13*~~::L?tr (%8'(;) '§* 8 M (%8£) 13* y #tl~I7Z *f 'f ,. 
o tf ± ::u f£;( ;tn~j 'iff '*f ~J ~rn -== ~W(1 
'If* 3 Emf;g (O'J ~-~ III) f¥f¥l1iHY$}3!l*m.§!f~ , :pH~~ 0 
W ~·W@#t~*~~~¥~e~¥·~~~~.aIijT 
,~-.~a••~,.#~*~ ~~~~~~W~~ 
15 fu.13*~~::L#f~ (%zO 13* g M «tClZ9) EI* \f • ~~1I *P~J 'z 
*••m~m~~~fi~.w~~m*M' ~£~ M • 
• Z~ ~~Mm.~.'*~~ .att .~li .~tiM 
~ ""f I!m ~ ifJi. M ~ H: § ; Llt ~ )jtl ~ -IN: m* • • ~lj m 
;ft C1 ptg ~ J[ *~.~~ (4) 'f!1§ ~ ra' § l& f.!li ~ fIE f.!li it ~~ Jf Jtr 
~~. ~,oo o~~~;~~~ft~~~Jf~~~~~oLlt 
9f. ' ~ ~ iNii ~~ ~ t:f: f.!li it~ f:!Il ~ • a ' ~ tJ • ~ 11) ~ I¥J ~. 
J6~ ElifJi.~fi~:91J ~~ 0 
®~~~$ m. ~.~~••• ,.*m.~~~~; 
fj 00 * 1m ~ ~} § 56' ~ ~ it ( ~D ~ t& ~~ ) ~mUm J%' ~ ~Ij ~ ~ 
ffi~.o .~ m~*~tl~~ ~~~m~o&~~~~m 
~1 (carrying agent)' JI~ 1'& i~ , ~ If ~ iJ1Ii I¥J 1!t.1J (9) , f!1§ fIE ~ 
~~ ~~.~*1!t.A~~.~~ffi~~••~*. ~mtt 

o~Llt'~B*~~ .~.~~~~*o~~ ~~m ~ 

it ~,~ Llt :g A. fltf ~ /Ji WtJ m~~~ r:p I¥J -..... ::t ~ f.!li it: ~ 1{ 'fit: 

- 113­
~ 0 ffiJ m! ~ ~~ T ~U ~ :F~ ~ f!f ~ it /G $!. (16) 0 
-&ffiJ '~E~~~k~fi~.m••a ••tt •• ,j 
EIP B i~ 1~ Cl ~ ~6 ~~ 1: 7'C iW '~ ~ 1t ' lIt ~~ ~ It1J ~~ tlo 1J§ 1f- Z f.ti it 
~fflo~l1t~*~~•••m~M~~aCl~~~~ili~'~ • 
.<: ~ 1t : IflHffI ( ~ ) E ~ , 1*, no A & j}'f ttl if~ " E ~ ( EI3 ~ ~1iff 
mJlJ(; m~ EE ~f ?P 1t ftB j;fu l!I .<: E ~E (lime stone) m~ iffi nJ(;) " & ~ 
~~M~JlJ(;o~~~kmE~~••~~~M.~ ••~~® 
a£m!(10,17) 'i'lJt!- WUlf{fFm~~' k·~~aY:~J!P~~@J1~IEm-0 
* 1itf ~••• :F~ p), E ~mmt ~ :f* Ib W Cl ~ ~ Ik¥ ra'1& ' WI fl ij I~ 
.~ft.~ ~~~~,~~tt~ "~~k~~1:"~~~ 
it " ~ it ~ J3t ~:fiE Xk 0 lIt EIP ~ ~ pfT g~ Cl ~ k m~ ±W 1: h ';% ~ 1:~ 
~ i~:@(; it ~~ tt ( ~!fo/J ) i~ ~ 1& ~ - mif;f:i. J:: ~~ J}] ijE; 'I~ IYg Bill ~ 
* :Jt:W 0 )tlt: ~ J}l :@(; *~ *~ --~M ra' ~ m: ~ 'I~ ,.~ , wU ~ , ifIjij I0 
~k~±W~~."/G~o~l1t*~~M.m~.~-@.~tt. 
?1& (mechanical irritation) ~* ,tlo 1.$:.,~~~~~~~3*~4m-~ 
WI r~j ( m f[~ fj) fi ~ §G ~ ~ a Cl ~ ~ :k'tHffi ~~ 1S ;f~ ~ it W;i~!H' tt 
~m.~~ww~~~~m,~m~M~•• ~tt~$~.~ 





~mnt ' if'~1&~ 12 ~~It~~Hl~~~H~~ , ~*~:f5l A, B *,HwH± 
~7&~~~~'$.@Jmrr~~~~1S.ol1t~~*~.tt. 
-114 ­
mSirsat W Khanolkar(S-6) flj mfr-U ff~ Iii W1i ~ 1B:3:. It:<, 1ft capsaicin 
(non-specific reaction) ~':6 J;f! /IIJ:f~ W:J ' ~- mm It';;$: mfrg WJ 3& k§ ~0 
H~AmlB~._E~~ m~'. lliM.~~fi$1B ~a 
(alkaloid) , IB ~Mm a arecoline ;f11 arecaidine ' 1± 
~~.~,~ ~••E~~M'/IIJ~& ~~~.~ e ~ 
170% 1B:lli 9llin:/~ _~ (\ j ~m J1t Z >,t ' E8 It' ~ 97 1m 1m M B'J r15ltrlJ ' ¥J0 
0(hypersensi ti vity) r .}1'{ m m J (collagen disease) Hamner ill 
(1970)(14) ~~ ~ 1i ~ 1± Ell Bt tl! 11 ~it ~ {tr: *ot ' fN I3J nl§ f1 ~ EfJ 
It A Tffl tl!.~ f.i ~~.9: ~ (allergen) , rm iff Wl ~± ~ l1'Z 1~ Z~;fi ~ ~ /.$: 
1M T I3J ~ JJ\! III {j't ~cL ~ J;J:&.,~ :fl-ltn t1i ~ {j't n f::jt:biif ~ (eosinophilia) 
Z J~ ~ (14) lit RP ~~ ~ &fl. tt ffi{ [§ : ill ftt!:;]ft /f ~:iIt 1W;;$: ~0 
g!(; fi ,'if},!It m~± Z ~ [ZSJ * 0 E8 ,~$li * tR J~ A (85%) ~J1:f;fiJ B (88%) 
&11 z aa .. :Fi ,~, /f f~ J!if z ~~ ~~ Hf 1t Wi ~± ' fS :;]ft:1F -8,j-
S ~ 'l1:fL~, $ , k§ J1t rt ~~~ (14) pfT:m::iIt 1. ~ :W ,["£ 111 f1 JllJJ fIJ.9: Mi BZ ~ 
z gfiB fP.li ' fJt RP M • !Jl A A I3J llll III ' {fLTIE:1F 00 00 111 ~ fJl§ ~ ~ 
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o 
AS D~~.m.~*€m~m~.*.~w* • ~ 
.*~tl~~.~m$~.~~~ ~ ft'fi~~~m••~ 
~ ~~ T ~ *I ft ~ ,Fjt 3), 7(' & A • ~ ~ ~ ft m: * ltJf ..~0 
1m: ;JA 
.... \' iiffif 1m ~.fi •••m~,*~~~* M~'~~.~ 
~~$M ft ;;(:*m~t.g£ ; 35 1J lID ' :fa ~ IIl& 3 6 ~ WJ ra' ~ ~~* 
PfT 3& mkt M£ ~ ¥:t (z[l fIT f!k 37 :f:t] 30 iF ) 1111 C fl ff!Ii ~ -fj 
* l:lt JM 
(1) *x 
EU 0 
~ $: rp ~ ~ • ~ %f3 84 fl:ti ft.!. ~ ( N; ~ 80 if:: 
1 I f3) 0 
~$:)( ~ ~ ~ $: ~ JOO * [] ~ ~J!i ~ ~ 1iff"1M (April. 22-25, 
1992. Nagoya, Japan) 0 




Areca catchu L ilifflJ-lf1f) , (betel leaf of piper linn) " 
~ 1£ (Inflorescence of Piper Betel) 79.. ~ 15 t:k. (slaked lime) 
~m ~~m~:~~m ,~~~~,,~~~ 
~o®~15~~~Q~' .~m~m~~15~EM.OO 
~o m~ ~~~~~'~~~~~~*M~o ~~ 
~ (leave of Piper Betel) 1* 
,~~"tt~ ,~~~~~~~~~~~ 
.~,~.~a~w~o~.~ _M.~mM ~ 
~, w~mtt~~m~~~. m ~E~~1*~ 
~~~~*.*:~-miliffir~~J '~~~~ffia~ 
.~.~, ¥~~mmE~'~~ mff.~~.~' 
~,.,. ~~'~~~~~.~~~~••moM~ 
~M~ W ~~~~~~~.~~ ~,~~~~-~ 
_*0 
~l= : :fJim_~ (Betel quid) L~J{)(~$ (Extraction of betel quid) 
1* ffl Ranadi ve (1976) ~m~±Uf'~ .l-:A {if.t M: EfI (DMSO) m11I 
~J * ¥ J{)( (7) ° 
~ If} Ft L.~ '.~P .L')' M:ft!~ (nut of Areca 
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Edfct *I 1]( if.] f4 (sl aked lime) , (=').L-:A 1* @ Wf E 1]( ~~~ tg 
.M.~o.~~$mM.~~liO~& ~~m••­
Ej3 j!.::::: 00 ff' ~$t~~JfH!!!~Lttffm~~~mI#* ' tii~ 4­
5 °C Z {JjCf§ V':H~ mll!9 + J\ /J\ m¥ ' fij tJ[J A f§!OJ m;f!YlJ =OO?i 
ff~'~~~z~~~~'~~ ~~~~ ~~~~# 
~ 4-5 °C .(;K mj7g 0 
n=:*~ tt .~~4.~~ .*~~~MD~~.~~ 
~m .~M•••U'~~~=: £~#.*m~~ 
1*~~~.~~~D~~.z~~tt. ,~m*~m 
;r.'- .~± T ~ htt 'Il'+ ::II:::
jP'j '" . / J %CC'T~ ::F'J 7'1-' 'f!t, JtJj 'toi tt lFU ~ :7'\-~ z JJl ~ 
* Ffl f'V: • *1 1t fP\):I:1 (~) Mm.*1 ** 1D:: lM ~ 1& ~1l mJ ' l' 1I fi.0 
~~~~m'~m••~~~~~R .~o 
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~.w. 5 ~a~ t ~ J.R. (A) l4 ~iR. (8) ¥.Ii #l~ ~ lf~ ~t ,iilij !.W.{t ~;fif 0 ~ tb mtIII 5- 1 . . . 
.if .9t~)jf;rJ.Z-.JJL t-. 0 .~#: 12lli~~ , f=J!:X (C) ~,~r.~ (D) ¥Il#(t4lfsut 
~m~~~ ~o~~~~~~.JJL~~f=J~~~a~~~~~.Z-~~ 
it sf) ~Y-J:J;±. 0 
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o Ti-2'f."";f t't~ ?1~1JJt ~*ali ~1fr,*..kl1ff#~D"";f'W ~lf1C;El-KAk*~¥t (0)?f:I1 (J)?ft~ , ~1ifr 
9£ tt~ ?qt~~~~lJf"~lf!f* ± -,*iflflf ' ~~T:(.~~ ~*7f..k I ~ 0 
l*.Itff~fo~)J~1f~~+~~*~.f>t: (9) ¥{:r~~ ('If) ¥{~ '.tB1iifVZ'#~ Z-g III 
11]5- 3 ~~36 jlijA~ , a~!4jJ:J.R.~~~lf~rrJifu~iia ~\. ' f&t~!J 12:i!!~ It 




o (0 ':)"t?ff-:r 
¥ !t!!' Jr~~~Tt-~-:r~~4"f.1'I$*-:r*~~W' (8" 'V) ~leJ-~y*~±~ 
i\14JlIHiiF zr 4ff})ffJ , ')g ~lf~ftJ -t·r~1r~~·~~:t:1~~1$ , lH~'F 9£ tf~ t -9 III 
III 5- 5 ~:tf.. 5 :i1!l* ' E1 ~~JL~~~~Jf~~t ~ m.z...L Jt.i§.~fiJ 'it -ft ' .¥.. -* 
.&A~~~~'Jt.TM~m.~~~M.~•• 'A*~~~~ 
"#!~JIe (fibroblasts) JE. ~~!t ~ , k.T~~~~·:f , ' 1t. .mz. VA&.~tt 
!R.'ti~Jl@. (A, B) ?£:tf.. 12 l!!ot ' E1~~.k~~~~"'~.)t WJm~Jt.T0 
M~M.~~JLj'J~Mlt a}J~ ,ti ~~'¥"JJL*. ~~'\..Mt, .*-n~~~i!..Mt.~ 
~.M -~'.mz.*.*~•• ' ~~~JIe*.~A.U~~* ' ~ 
'i.z..M.Itl ~ H:. , }}f~ .Mt*~1.pA.M.rk1Ji (C,D)\ 0 :(A,C: H & E 
X100, B.D: Lillie modification of Masson T r ichrome XIOO) 0 
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IiJ 5 - 6 	 ~#. 24 ~at ' a J.K. ~!1:~;J,l~¥ Jf~.jt ~m-tJt. """F M ~§:~J}f J.Y. 1.. JJl. 
t~~~~li ' .~••*~4 ' ~••~~~~~~'~.M. 
~ (fibrocytes) ~ ~ , kif ~t~ , ~,/1,~~ #JtIJo ; ,'*'* z1JJLrl:) l.~ 
$-t~,/1, , m1lJ~.!1t*l%r*,"~ (A,B) 0 
~#.36~* ' .J.Y.I~~~4~~li'.~~~~~••~~'. 
;g. .fl,J ;t~f1i~~ ~ *" I )1). J.l-~ ~ ,/1, ~ JJe (C.D) (A, C: II & E0 
XIOO, X400 B, D: Lillie modification of Masson Trichrome XIOO.I 
X400 ) 0 
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Part 5. Dimethyl Sulphoxide Extract of Betel Quid Inducement 
of Oral Submucous Fibrosis (OSP) on the Buccal 
Mucosa of Wi star Rats 
To consider the limited specImen of human buccal tissues from 
incisional biopsy procedure, the extract of betel quid inducement of 
oral submucous fibrosis (OSF) on the oral cavity of animal will be 
needed. The further investigation (both in vivo and in vitro) for OSF 
can be engaged by this induced lesion via local painting of dimethyl 
sulphoxide (DMSO) extract of commercial betel quid. Chi llie 
consumption, nutritional deficiency, betel quid chewing, genetic 
susceplibility are believed to be involved in the pathogenesis of OSF. 
Chillies are the common seasoning for food in India. Betel quid chew-· 
ing is considered as a primary etiologic faclor for OSF in Taiwan. 
Sirsat and Klanolkar (1959) elicited a connective tissue response m 
protein-depleted or vitamin B-deficient Wistar rats, which they 
described as experimentally produced submucous fibrosis, by use of 
extracted capsaicin dissolved in thiophene-free benzene (2% concentnl.­
tion), the reported irritating ingredient in chillies. The exact nature 
of this lesion process remains unknown. 
A series of my experiments are in progress to trace the possible 
etiology of this lesion. This paper reports and attempts at the induc­
tion of OSP on the buccal mucosa of Wistar rats (60 males, approxi­
mately 4 weeks old), by local painting of DMSO extract of betel 
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quid (both A and B groups), lime (C group), slaked lime (D group) 
and control solution of DMSO (E group) with separate camel hair 
brushes ;c;ix times a week for total 36 weeks. After 36 weeks of the 
experiment. either A or B group was divided into two subgroups. 
Either one subgroup for the continued painting of DMSO extract of 
betel quid or another subgroup for observation only in a period of 12 
weeks. In each course of application, the buccal mucosa was exam­
ined for gross and pathological alterations. The results are summa­ , 
rized as follows: (1) The varying degree of OSF on buccal mucosa 
induced via DMSO extract of betel quid application in either A (85%) 
of B (88(fo) group animals. (2) After 36 weeks of application in both 
A and B groups. the induced lesions in the form of patches with 
opaque appearance. Tn addition to the epithelial atypia, the underly­
ing connective tissue showed portion of homogenization of collagen 
bundles. (3) The induced lesions on the buccal mucosa of \Vistar rats 
(both A and B groups) were nol markedly reduced or absent after the 
end of experimellt with either the continued painting or observation 
for a period of 12 weeks. (ttl The human lesion of OSf is not identi­
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dysplasia) 23.<) ± 0.4% ' & Jjji {J'l.1M (carcinoma in situ) 31.4 0.9 
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1±1tfi':1'=J [J ~ 11 1Hl ftj§' ts *HI ~ z tiff o/C ~ (7 -8) , [l;I t1t ;4>: ~ 1iJf ~ lJ 
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,I~, ,m ~ MacDonald, Katz, Pindborg :if ,E:iJT ¥~ 1lj-~m:@ ~fl ~ ~ 
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1=4' pfj- f-J ~ *ffi ijfg ~ r:p , ~~,rJ} ~m~J:± In''k ~JI Ml f~ ft jt( 4 00 W00 
(c;ecrion ) ']111 00 ~- iiz Wml ~ 1=1 250 iff!! '* 1f.m ~, ~ ~ $tO ~) 
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_-l>­
3~~ tE. • RP I:U 1'£ :r-\, mt ~ ~ f'- (transmission electron 
microscopy) W ~ jU:ill: ~(Q kif! f:fflJ ~ ttH!~ ~ ~ ~ " /f.:1fff}i:; i?v'Ul+ 1nt 
flJ mWilcoxon signed rank test, X iff! IE ~ 0,05 ' ;fi p f[~ /J\ 115:- 0.05 ' 
~ /]"' -fr'£:t;;-+1.:1: ilYL rfi ~ ~ ~o 
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2) '§M~~ ~ *~ ~r ~a~, ~~~M~ ~~ 
W; ftg ~ 5 'fffi 13t ~ ft IJ ~* 1ffi Z ~ *,1 f115fiHtH IfMf tt tt ~M JJ \ 
III : ¥:l 7l :(£ tt: J!:I jf ~ ~ tm ~ tf: • ~ ~ *ill J1B raj@ z J1B ~ I J \ tm 
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IV ~~sI~ ¥t ',!t (6) 
V ,rw,: 1~ (6) 
*.@~m2£~S~U~,g.~~~~4@W~· 
fiff1'f 1~£~*lllfl§~::J:t:;tj 1000 @ c 
+ fi5 5Jll i:kJ I): + flD ~ 19IJ I~ c 
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iii tj/, z 8' 7Y * (;s)* 
30±0,2++ 
iO,6 ± 0.6 
22.9 ± 0,8 
23.9 0.4 
31.4 ± 0.9 
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~n ~ 
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Part 6. Dark epithelial cells in oral premalignant lesions 
Oral submucous fibrosis (OSF) is a chronic oral precancerous 
condition. The atrophic epithelium first becomes hyperkeratotic and 
later intercellular edema and basal-cell hyperplasia develop, eventu­
ally followed by epithelial atypia with moderate epithelial hyperpla­
Sia. There is a good correlation between the degree of atypia of 
rodent and human epithelial preneoplastic lesions and the numher of 
dark epithelial cells in the respiratory tract mucosa. I attempt to 
correlate the distribution and frequency of these cells with the clini 
cal type and degree of atypia in these lesions such as oral submucous 
fibrosis and leukoplakia. 
Dark basal epithelial cells (D-cells) are characterized by a strong 
affinity for basic dyes and by the high electron density of the cyto­
plasm and nucleus. These cells have been considered to be pulati ve 
dedifferentiated precursors of neoplastic kerationocyte. They are 
significantly increased in preneoplastic lesions of lhe human airway 
and rat trachea induced with chemical carcinogens and/or tumor 
promoters. Twenty-four cases of oral premalignant lesions were classi­
fied as mi ld. moderate and severe dysplasia, and carcinoma in situ 
according to the histologic criteria proposed by MacDonald, Katz and 
Pindborg. The percentage of appearance in D-cell of the dysplastic 
basal layer was calculated as follows: in mild dysplasia 10.6 + 0.6%, 
in moderate dysplasia 22.9 + 0.8%, in severe dysplasia 23.9 + 0.4%, 
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and in carcinoma in situ 31.4 0.9%. 

This result revealed that the increase in the number of D-cells in 

the basal epi thelial layer was in proportion to the severity of the 
epithelial dysplasia. Thus, the D-cells probably can be used as an 
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Lai DR, Chen HR, Lin LM, Huang YL, Tsai CC: 
Clinical evaluation of the different treatment methods for oral submucous fibrosis. A 10­
year experience with 150 cases. 
J Oral Pathol Med 
Abstract: 
Over a lO-year period (1982-1991), a total of 150 patients divided into two groups with 
varytng degrees of oral submucous fibrosis (OSF) were treated by two alternative thera­
pies: either (1) medically with (a) conservative oral administration of vitamin B-complex, 
buflomedial hydrochloride and topical triamcinolone acetonide 0.1 %. or with (b) conven­
tional submucosal injections of a combination of dexamethasone and hyaluronidase or (c) 
with both (a)and(b); or (2) surgically by the excision of fibrotic tissues and covering the 
defect with split-thickness skin, fresh human amnion, and buccal fat pad (BFP) grafts. 
Treatment was chosen according to the stage of clinical progression to gain maximal 
interincisal distance (10). The cases were followed up by monthly examinations for at 
least two years, or when possible even longer. We found that a combination of (a) and 
(b) medical treatment was satisfactory in cases of mild impairment in 10 of>20 mm, but 
in the long-term it led to symptomatic relief only. Surgical therapy on the other hand, 
when accepted by the patients led to a significant improvement of trismus in cases of 
severe limitation of 10 of < 20 mm. Following this strategy, an additional 10 increase 
was observed in all patients. BFP grafting was particulary successful in diminishing scars 
after two years as compared with the other two grafts. Together with a cessation of the 
betel quid chewing habit before and after therapy, these treatment regimens combined 
with daily mouth opening exercises were found to be necessary to properly manage OSF 
cases in early and advanced stages of progression. 
Key words: 	 Oral submucous fibrosis; betel quid chewing; interincisal distance; submucosal 
injections; carbon dioxide laser; split-thickness skin, human amnion; buccal fat pad. 
Der-Rong Lai, School of Dentistry, Kaohsiung Medical College, 100. Shih-Chuan 1st Road, 
Kaohsiung, Taiwan, R.O.C 
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INTRDDUDTlDN 
Oral submucous fibrosis (OSF), a disease due to an insidious, chronic change in 
fibroelasticity, is characterized by a burning sensation in the oral cavity, blanching and 
stiffening of the ora! mucosa, and oropharynx, and (rismus(l). The symptoms/signs depend 
on the progression of the lesions and on the number of affected sites. More than one oral 
site is involved in most cases. OSF has been reponed to occur commonly in conjunction 
with other diseases, such as leukoplakia( 1-2) and lichen planus(3). In advanced lesion, the 
fibrosis extends from Lhe subepithelial lamina propria through the entire submucosa, to the 
muscle layer. Thick inextensile vertical fibrous bands appear in the cheeks, faucial pillars, 
and encircle the lips. Narrowing of the oral aperture caused by circular fibrous bands in 
the lips is nOl only disfiguring, but also limits oral access, leading eventually [0 malnutri­
rion and poor oral hygiene. It is considered to be a premalignant stage of oral cancer, 
affecting predominantly Indians and other Asians(l,4). A high proportion of patients who 
develop oral cancer are betel quid chewers and sometimes habitual smokers and/or alcohol 
consumers. These findings are associated with an increased incidence of leukoplakia and 
squamous cdl carcinoma(5). If untreated. the risk of malignant change in advanced cases 
of OSF is relatively high. 
A wide range of treatments such as medical management(6). surgical therapy(7-ll), 
and physiotherapy(6) have been attempted in the past, with varying degrees of benefit, but 
none of them have proved to be a cure for this chronic fibrotic disease. In this article 
we present our experience in the management of early and advanced cases of OSF over 
the past 10 years, and propose an effective regimen for the treatment of [his disease. 
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Materials and methods 
One hundred and fifty patients (males: 145, females: 5) suffering from OSF diagnosed 
clinically and pathologically as having submucous fibrosis were treated at the Kaohsiung 
Medical College Hospital, Taiwan, over a period of 10 years(l982-1991). The criteria for 
diagnosis of OSF were based on the blanched, slightly opaque and fibrous bands of the 
oral mucosa(l2). The clinical diagnosis was confirmed by biopsy in every case. A detailed 
personal history, with special reference to smoking, alcohol drinking, and betel quid chew­
ing habits was obtained from each patient. Routine blood/urine tests were made and radio­
graphs were taken to exclude associated diseases. The distance between the incisal edges 
of upper and lower central incisors with the patient's mouth fully open was measured by 
using a special scale (Mitutoyo, Japan)(Fig. I). Patients with temporomandibular joint prob­
lem and pericoronitis of the lower third molars were excluded from this study. Before 
treatment, a cessation of betel chewing habit and full mouth periodontal scaling for all 
patients are required. 
The patients were divided into two groups. Each group contained 75 patients. Ages 
ranged between 17 and 68 years. The group I and 2 patients were further subdivided into 
subgroups A, B, C. and D, E, F, irrespective of age. sex, according to their initial mouth 
opening as measured by the interincisal distance (ID). Subgroups A, B, and C each 
consisted of 25 patients with ID ranging from 20 mm to more than 35 mm(Table 1). Sub­
groups 0, E, and F each consisted of 25 patients whose 10 was less than 20 mm (Table 
2). Group I patients were treated by medical management. Subgroup A patients were 
orally administered vitamin B-complex tablet in a dose of 200 mg twice a day, buflome­
dial hydrochloride three tablets (450 mg) per day, and topical triamcinolone acetonide 0.1 
% on mucosal ulcers at bedtime. Subgroup B patients were given biweekly submucosal 
injections of a combination of dexamethasone (4mg/ml) and two parts of hyaluronidase 
(200 u.s.p. unit/ml) diluted in 1.0 ml of 2% xylocaine by means of a gauge 27 dental 
needle, not more than 0.2 ml solution/per site for a period of 20 weeks. Subgroup C 
patients received both the oral medication and submucosal injections as itemized above for 
Subgroups A and B. 
Group 2 patients were treated surgically. A Sharplan(Israel) hand-held carbon dioxide 
laser(C02) laser, at a power setting of 20 watts in a continuous mode, was used under 
general anesthesia for the exdsion of circular fibrous bands in the lips. Then, linear inci­
sions were made with a knife(No.15) along each side of the buccal region, extending 
from the commissure of the mouth upto the retromolar area. The incisions were enough to 
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expose the underlying muscles. Then a metal prop (Mysco, Japan) was placed into the 
patient's mouth to hold it in an open position at an ID of 30-35 mm. After access was 
gained, the gross fibrous tissues in the posterior [hird of the buccal area, pterygomandibu­
lar raphe, and faucial pillar were excised. To repair the resultant defect. either (a) a split­
thickness skin graft harvested from the patient's thigh for subgroup 0, or (b) a single 
layer of fresh amnion obtained from clean vaginal deliveries of serologically nonnal 
women for subgroup E was grafted over the wound. The graft was carefully contoured to 
the surgical site to prevent tenting over any depression in the defect Then, a prefabricated 
resin stent of a round, curved shape with tissue conditioner. was molded to the defect 
after its initial setting. The prepared graft was wrapped around the compound stent 
smeared with a thin layer of Dermo-glue and sutured to adjacent buccal mucosa with cross 
stitches. 
In o.ubgroup F patients, buccal fat pad (BFP) was mobilized through an intraoral inci­
sion in the upper buccal sulcus 5.0 mm above the attached gingiva. 20 mrn posteriorly 
from the maxillary second molar. With gentle traction, the pedicle fat was pulled over the 
wound and was lightly secured to the margins of the buccal defect with 3-0 glycolide and 
lanile-coaled polyglactin sutures. 
After surgery, patients were fed on a liquid diet through a fine bore nasogaslric tube 
[or a week. Two weeks after surgery, patients were asked to perfonn daily mouth opening 
ext';..:i~e': and they attended our outpatient dental (OPD) clinic for a 4-week follow-up for 
{he forced mouth opel1ing by a metal prop (Fig. 2). Follow-up sessions were repeated 
monlhly for all six subgroups for at leas! two years or even longer when possible. The 
imprnvenlcnt in mouth opening was evaluated by measuring the ID hefore and after the 




After a month of oral treatment with vitamin B-complex, peripheral vasodilator (i.e. 
buflomedial hydrochloride), and 0.1% topical triamcinolone acetonide, the symptoms of 
subgroup A patients were quickly relieved, although there was no improvement in their 
trismus. Most subgroup B patients (83%) given a course of 10 submucosal injections of 
hyaluronidase plus dexamethasone felt relaxation in the stiffness ~of their buccal mucosae. 
Subgroup C patients treated by both of the above modes of treatment of subgroup A and 
B had early and marked relief of symptoms. However, little difference was found in the 
improvement both in trismus(subgroup B: 83%, subgroup C: 86%) at the end of treatment 
course and the decrease of ID in the range of 3-5 mm (subgroup B: 69%, subgroup C: 
66%) in the two-year follow-up. No patient developed infection at the injection sites in 
either subgroup B or C. 
Visual inspection of BFP graft revealed satisfactory healing within 2-3 weeks after the 
operation, yielding a good mucosal surface with minimum morbidity. In general, surgical 
treatments (subgroups D, E, and F) resulted in significant improvement of trismus in 
patients with severe limitation of mouth opening with ID of < 20 mm. Increases of mouth 
opening of ID were noted in all surgical treatment subgroups after 2 years of follow-up. 
Grafts and wounds contracted in all patients by varying amounts; most for fresh amnion 
grafts and least for BFP . During the following two years the lD declined by 5-10 mm as 




Aborigines excepted, betel quid chewing in Taiwan is a predominantly male habit(13). 
The sex ratio of victims of aSF in this study was 145: 5 in favor of males. Clinical thera­
peutic evaluation was based on the relief of symptoms such as painful ulceration. burning 
sensation. blanching of oral mucosa, and limited mouth opening (Table 1). 
Many of the patients al our OPD clinic complained either of hypersensitivity Lo spicy 
food and irritant substances or of the severe trismus. The former asked for the symp­
tomatic relief; the latter for improvements in mouth opening. A decline of ID at maximal 
mourh opening corresponds to the degree of OSF lesion and a change in ID was a treat­
ment criterion in our study. The improvements in subgroup A patients with maximal 
mouth opening of ID of > 35mm were restricted to symptoms other than ro changes. 
MARTIN et al.(l4) considered vitamin-B deficiency in the etiology of degenerative 
changes in oral mucosa before malignant transfomlation. SIRSAT et a1.(15) reported that 
the reaction caused by capsaicin in arousing a limited connective tissue response was 
enhanced by vitamin-B deficiency. Thus, administration of vitamin B-complex may relieve 
glossitis, inflammation of the tongue, and cheilosis in OSF patiems. The peripheral 
vasodilator, such as buflomedial hydrochloride affects the tissues in diffuse fibrosis to a 
noUceable degree by the relief of local ischemic effect. SHAR]\;iA el a\.(16) observed that 
the OSF symptomology included local ischemic effects secondary to local fibrous condi­
tions. hyperkeratosis, and loss of suppleness. Therefore they reconmlended peripheral 
v3sodilator (a) to relieve the ischemic effecl and (h) to aid nutritional and therapeutic 
substan..::es in reaching the affected tissues. We thought this to be effective both in the 
earlier and advanced stages of OSf iesions. Additionally, steroid ointment was applied topi­
call) in cases with ulcers and painful sensation of oral mucosa. Its therapeutic effects were 
ntdinly anti-inflammatory and appeared to have a direct healing action( 17). Steroids are 
well known to act as imInunosuppressive agents for prevention or suppression in fibropro­
dUClive inflammation found in OSF lesions and therefore ameliorating this fibro·collage­
nou,; conditiollt 7). Hyaluronidase in enzyme treatment of local inflanunation degrades the 
hyaluronic acid matrix. actively promoting lysis of fibrinous coagulum as well as activat­
ing specific plasmatic mechanisms( 6-7). Therefore, a reI ief of trismus may be expected 
through softening and diminishing of fibrous tissues. The symptomatic relief of burning 
~ensation, feeling of stiffness, and disappearance of vesicles were abo noted after five 
submucosa! injections 01 a combination of steroids and enzyme. This could explain why 
our sub-group B patients treated with such modality showed more improvements than 
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those in subgroup A. 
There is a decade of experience with the dual mode of medical treatment given to sub­
group C, leading to a long-term reI ief of symptoms. BROLE et a!.(I 7) stated that the 
mechanical insults due to insertion of injection needles and chemical irritation of injected 
fluids after a certain time aggravated fibrosis, trismus, dysphagia, and morbidity due to 
the progressive nature of the disease. We sought to improve this technique by (a)injecting 
not more than 0.2 ml solution at a time at a given site by means of a gauge 27 dental 
needle, (b)massaging the cheeks with the mouth closed, and (c)asking the patients to 
perfonn mouth opening exercises for 20 min. after the submucosal injections in our OPD 
clinic. 
OSF may be caused by many factors. According to CANNIFF et a\.(9) the oral 
mucosa of OSF patients is genetically predisposed to chronic inflammatory changes upon 
betel quid chewing. It is usually initiated by chronic inflammation. and the progressive 
condition may be precipitated by poor oral hygiene and malnutrition due to severe trismus. 
For these reasons, surgical intervention is essential, especially for patiems with an ID of 
< 20 mm, to relieve trismus at least for a period of time. Thus our choice of criteria for 
surgical treatment meets the patient's requirement. 
To relieve severe trismus in OSF presents a difficult surgical problem. Several proce­
dures have been proposed in the past, such as excision of fibrous bands with or without 
grafts. Materials for attempted grafting included skin or placental grafts(7), tongue flap(8), 
splits of the temporalis tendon and coronoid process(9), lingual pedicle tlaps( 10), and naso­
labial flaps( I i). These grafts may certainly relieve trismus for a short period. The bilateral 
full-thickness naso-labial flaps technique was the only possible extraoral approach(I I). 
Because this operation leaves external facial scars, it was not recommended by oral 
surgeons_ Disfigurement of the face is not acceptable to our patients according to the 
Chinese social cuI rure. 
Our patiems with varying degrees of inability to open their mouths were noted irre­
spective of rhe disease stages. The main clinical criterion adopted for grading OSF cases 
was the presence of palpable fibrous bands in the buccal mucosa. In 105 of our 150 cases, 
at least three fibrous bands were found encircling the lips, buccal, and faucial pillars. The 
constriction of oral aperture is not only disfiguring, but also limits access needed 
for surgery. To relieve this condition, the first task is frequently to excise the fibrous 
band around the lips by CO2 laser. Then the surgical access is gained. 
We preferred to use the CO2 laser, rather than a scalpel or a technique involving 
multiple tiny incisions for surgical relief of the limited oral aperture because the laser 
- 155 

beam spontaneously sealed all blood vessels allowing the surgeon perfect visibility and 
accuracy in excising the fibrous tissues(20). Furthennore, the laser excised wound heals 
with less contraction and scarring than wounds left by surgical excisions(21). With refer­
ence to the use of CO2 laser for the surgical treatment of OSF, we considered it be practi­
cally impossible to excise all fibrous tissues in the oral cavity at one time. 
50% of subgroup D patients had a relapse of decreased 10 of mOlIth opening in the 
range of 5- IO mm after 2 years of follow-up (Table 2). We altribute Ihis to the thin splir­
thickness epidermal grafts used for covering deep buccal defects. These grafls displayed 
pronounced contracture, and full-thickness dermal grafts which are known to contract little, 
would have been preferable for the larger mucosal wounds. Therefore the choice of appro­
priate skin graft thickness for cases of severe trismus is essential in the determination of 
postoperative mouth opening. 
The value of amniotic membranes as dressing for partial-thickness burns has been 
demonstrated by DINO et at. (22-23). Under no acute rejection(24), its application over 
parlia!-Lhickness defect provides for pain relief and even for re-epithelialization. In about 
62% of subgroup F patients (Table 2) for whom deep defects were covered by fresh 
aJllnion grafls, the ID two years after surgical treatment decreased by 5-10 mm. Therefore, 
fresh am"ion grafts would not appear to be applicable in a single layer over deep buccal 
defects. 
BFP had been llsed in oral reconstruction(18-19). In [he present study, we used BFP 
as a pedicled graft in subgroup F patients suffering from advanced OSF lesions. Our 
results confirmed previous clinical findings, that epithelialization did indeed take piace. 
Convenient and reliahle pedicled BFP grafts were used in the reconstruction of intraoral 
defecls IIp [0 4.0 em in diameter in the ipsilateral side of the posterior third of the buccal 
defect. Subgroup F patients treated with pedicled EFP group had the least percentage (38%) 
of decrease in mouth opening among our three recQnstlUction suhgroups. Technically, the 
surgical procedure is easy and the donor site is in close proximity to the posterior third of 
the buccal defect. Thus we consider this as the quickest and most efficient fonn of ther­
apy for OSF patients with severe trismu~ to emure long-tenn improvement in mouth open­
ing. 
GUPTA et a1.(7) reported that their 14 patients with severe OSF lesions did not 
respond to conservative treatment. They were all treated surgically using bits (lcm2) of 
fresh human placenta as grafts. After 2 weeks, this was followed by biweekly submucosal 
injections of dexamethasone for a further 4 weeks which led to definite relief of symp­
toms. Our clinical studies do not seem to substantiate these findings. Addirional follow-up 
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Injections combined with daily mouth opening exercises by the patients themselves may be 
needed after surgical therapy. We concluded that this proposed method may be useful In 
giving patients suffering from trismus improved long-term prospects after surgery. 
Betel quid chewing is rooted deeply in Chinese culture, especially among lesser 
educated men and blue collar workers(l3). Therefore, follow-up of betel chewers suffering 
from OSF on a regular basis often present an insurmountable problem. Frequently, after 
some improvements in symptoms upon an incomplete course of treatment a sufferer will 
not return to our OPO clinic. Such cases were excluded from the present study. However, 
upon incomplete therapy malignant changes may be present in portions of mucosa contain­
ing atypia in the epithelial layers, especially in cases of severe trismus, hence the need 
for long-teml, short interval surveillance. Chronic irritation caused by betel nut has been 
thought to be the local factor to induce the pathologic change of the oral mucosa(25). Our 
advice to patients before treated and participated in OUf follow-up study was to give up 
betel quid chewing altogether. OUf advice was accepted by all. The patients in this study 
found it easier to give up betel quid chewing than to stop alcohol drinking or tobacco 
smoking, possibly because of their fear for oral cancer, especially in severe trismus, and 
the fact that betel quid chewing tends to be a public nuisance anyway. Patients suffering 
from this incurable, chronic fibroelastic scarring disease need to be fully informed. It is 
essential at the onset of treatment to avoid raising the patients's expectations above that of 
the therapy. Many patients with a history of years of betel quid chewing come to our 
OPO clinic and expecl within a short period of lime a complete cure, which at present is 
not possible. Our treatment needs to be coupled with cessation of betel quid chewing and 
daily mouth exercises in order to manage properly OSF cases in both early and advanced 
stages of progression. 
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Fig. 1. The interincisal distance with the patient 's mouth fully open was 
routinely measured by using a special scale (Mltutoyo, Japan) before 
treatment. 
-158 ­
Fig ~ Two week s af ter surgery, patients were asked to perform the forced 
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